The Embassy of India in Seoul and M/s Humasis Ltd. signed an agreement today (April 20) for the supply of 500,000 tests to the Indian Council of Medical Research. The tests will be delivered to India in four lots, commencing on April 30.
This is the first purchase agreement signed by the Embassy of India in Seoul on behalf of the Government of India. M/s Humasis Ltd., whose factory is located in Gyeonggi Province, is sourcing raw materials for production of these diagnostic testing kits from India. This collaboration forms an important part of efforts to augment India’s testing capacity in the battle against the COVID19 pandemic.
Over the past few weeks, Indian agencies, including Central and State Government agencies and private companies, have sourced 450,000 tests (RT- PCR & Antibody) from various Korean companies.
This cooperation is in keeping with the Special Strategic Partnership between India and the Republic of Korea and the shared commitment of our leaders to pursuing a people-first approach.
This is also in keeping with the assurance given by Indian Prime Minister Shri Narendra Modi and ROK President Moon Jae-in that the two countries will continue to consult and support each other and share experiences in the common fight against COVID19.